This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BASEOFTONGUE_EXALLC for full statistics.
Malignant neoplasm of base of tongue
C3_BASEOFTONGUE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
188 |
4. Check minimum number of eventsNone |
188 |
5. Include endpointsNone |
188 |
6. Filter based on genotype QC (FinnGen only) |
188 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of base of tongue
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of tongue
- Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 188 | 46 | 142 |
| Unadjusted period prevalence (%) | 0.05 | 0.02 | 0.06 |
| Median age at first event (years) | 62.40 | 63.92 | 61.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 180
- Matched controls
- 1799
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
8974.8
196.5
152
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
160.3
129
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
498.7
126.9
113
6
130
Kela drug reimbursment
Malignant tumour
65.1
111.3
136
81
JDB10
NOMESCO Finland
Percutaneous gastrostomy
289.8
102.5
96
7
UJC01
NOMESCO Finland
Scopy of lower throat
177.4
74.7
74
7
WF002
NOMESCO Finland
Radical radiotherapy
31.0
64.8
90
56
A03FA01
ATC
metoclopramide; systemic, rectal
15.2
56.5
115
187
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
45.4
53.2
65
22
N02AA05
ATC
oxycodone; systemic
14.6
51.6
102
148
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
49.2
50.1
60
18
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
112.0
40.9
43
5
R4190
NOMESCO Finland
Nutritional therapy
43.0
39.1
48
15
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
22.4
35.2
52
32
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
+∞
34.5
32
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
143.8
34.0
35
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
68.2
33.8
38
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
76.9
33.5
37
6
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
86.2
32.2
35
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
15.8
30.7
52
45
A04AA01
ATC
ondansetron; systemic, rectal
16.4
29.0
48
39
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.2
28.7
116
408
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
19.8
28.2
43
28
GBB00
NOMESCO Finland
Tracheostomy
44.4
27.3
33
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
16.3
26.7
44
35
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
157.8
26.4
27
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
25.6
24
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
44.6
24.8
30
8
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
24.5
23
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
19.9
24.5
37
23
ZX095
NOMESCO Finland
Combined chemoradiotherapy
100.8
24.4
26
*
H02AB02
ATC
dexamethasone; systemic
8.6
23.7
56
90
A07AA02
ATC
nystatin; oral
13.0
23.2
42
41
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
249.0
22.1
22
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.8
22.0
117
500
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.9
21.9
46
60
ZX090
NOMESCO Finland
Other technic of radiotherapy
21.3
21.8
32
18
UDQ12
NOMESCO Finland
Flexible laryngoscopy
10.2
21.7
45
57
EBA15
NOMESCO Finland
Extraction of large number of teeth
11.9
21.2
40
42
SAA03
NOMESCO Finland
Extended examination of mouth
4.7
21.1
108
437
XX3DW
NOMESCO Finland
Time consuming IT work
7.4
20.5
53
96
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
223.6
20.0
20
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
52.4
19.7
23
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
31.9
19.3
25
9
A04AD12
ATC
aprepitant; systemic
31.9
19.3
25
9
A04AA02
ATC
granisetron; systemic, transdermal
9.1
19.2
42
58
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
43.6
19.1
23
6
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
+∞
18.0
17
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
198.8
17.8
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
17.7
91
351
WZC30
NOMESCO Finland
Teaching
5.6
17.7
58
141
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
29.0
17.4
23
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.2
17.3
37
49
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.5
16.0
44
85
EMB10
NOMESCO Finland
Tonsillectomy
12.1
15.9
29
28
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.5
15.8
51
120
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
174.5
15.7
16
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.9
15.3
36
55
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
35.1
15.1
19
6
A06AD11
ATC
lactulose; oral
5.0
14.8
53
139
K04.5
ICD-10 Finland
Chronic apical periodontitis
3.8
14.6
78
300
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.7
14.2
31
42
ZX070
NOMESCO Finland
Intensity modified radiotherapy
16.5
14.0
22
15
WX402
NOMESCO Finland
General anaesthesia
4.4
13.8
56
166
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
81.1
13.8
15
*
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
150.9
13.6
14
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
75.3
12.8
14
*
C02.4
ICD-10 Finland
Malignant neoplasm: Lingual tonsil
+∞
12.6
12
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
8.7
12.2
26
34
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
32.5
11.8
15
5
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
127.8
11.6
12
*
R13
ICD-10 Finland
Dysphagia
6.1
11.5
32
62
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
5.6
10.2
30
62
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
58.2
9.8
11
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
8.9
9.6
20
25
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.0
9.5
21
29
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
9.5
9
*
8085/3-C01.9
ICD-O-3
Squamous cell carcinoma, HPV positive of base of tongue, NOS
+∞
9.5
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
14.7
9.4
15
11
EBA10
NOMESCO Finland
Surgical removal of tooth
4.3
9.1
35
96
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
19.9
9.1
13
7
A04AA55
ATC
palonosetron, combinations; systemic
11.6
9.0
16
15
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
29.1
8.6
11
*
K05.31
ICD-10 Finland
Periodontitis pronounced
3.8
8.6
38
119
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
94.3
8.5
9
*
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
+∞
8.4
8
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
8.4
8
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
8.3
58
252
ED1AA
NOMESCO Finland
Mandipular X-ray examination
35.1
8.2
10
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.0
8.2
22
41
WW500
NOMESCO Finland
Blood transfusion
6.9
8.0
19
30
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
7.9
30
82
WF004
NOMESCO Finland
Palliative radiotherapy
12.6
7.7
13
11
Z51.5
ICD-10 Finland
Palliative care
5.8
7.7
21
40
R07.0
ICD-10 Finland
Pain in throat
5.9
7.5
20
37
WX707
NOMESCO Finland
Fiberoscopic intubation
83.4
7.5
8
*
K11.70
ICD-10 Finland
Hypoptyalism
83.4
7.5
8
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.3
7.5
22
46
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.1
7.3
17
26
ECB20
NOMESCO Finland
Oral alveoplasty
31.4
7.2
9
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
9.4
7.2
14
16
WX110
NOMESCO Finland
Local anesthesy
2.5
7.1
131
937
R21
ICPC
Throat symptom/complaint
3.4
7.0
35
120
UDQ22
NOMESCO Finland
Microlaryngoscopy
11.6
6.9
12
11
T05
ICPC
Feeding problem of adult
41.7
6.8
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
12.9
6.7
11
9
K05.30
ICD-10 Finland
Periodontitis complex
3.0
6.6
40
156
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.7
6.6
28
85
UJC02
NOMESCO Finland
Rigid oesophagoscopy
15.0
6.5
10
7
QA7S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in jaw or lips
72.3
6.5
7
*
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
72.3
6.5
7
*
J02AC01
ATC
fluconazole; systemic
2.4
6.5
63
326
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
6.3
6
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
4.2
6.3
23
61
SBB10
NOMESCO Finland
Teeth copy
4.3
6.3
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
103
147
14.29
77.45
1.6
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
50
28
23.96
64.29
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
582
5.26
26.05
3.0
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
113
493
4.24
21.30
8.1
3.6
mmol/l
2.4
2.3
3.36
105
427
(3013650) Neutrophils [#/volume] in Blood by Automated count
154
882
5.13
18.94
14.5
9.6
e9/l
4.0
4.3
0.72
142
783
(3044640) Blood type and Crossmatch panel - Blood
99
502
3.05
12.83
3.3
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
82
382
3.03
12.25
2.9
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
81
388
2.91
11.33
12.7
6.7
—
—
—
0
0
(3002256) Pathology report gross observation
51
190
3.31
11.03
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
120
716
2.87
10.92
4.6
4.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
15
9.24
10.35
1.3
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
112
670
2.66
9.74
6.2
8.4
inr
1.1
1.3
2.13
28
183
(3024561) Albumin [Mass/volume] in Serum or Plasma
113
693
2.58
9.12
7.3
5.2
g/l
34.8
35.2
0.34
105
652
(3023368) Bacteria identified in Blood by Culture
85
461
2.54
8.84
5.3
4.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
63
4.22
8.55
1.2
1.2
iu/ml
215.2
85.9
—
8
17
(3022096) Basophils/100 leukocytes in Blood
110
687
2.45
8.24
6.9
5.9
%
0.6
0.7
0.87
101
648
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
111
707
2.39
7.80
6.4
6.3
mmol/l
1.2
1.2
0.14
103
625
(3007853) Bacteria identified in Skin by Aerobe culture
45
190
2.80
7.61
1.8
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
110
703
2.36
7.60
7.0
5.9
%
2.3
2.9
3.30
101
662
(3019069) Monocytes/100 leukocytes in Blood
110
706
2.35
7.49
7.1
6.2
%
9.5
8.9
1.05
102
671
(3003694) ABO and Rh group [Type] in Blood
73
393
2.40
7.46
1.6
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
80
450
2.35
7.39
4.6
4.0
ph
7.4
7.4
0.51
17
77
(3006315) Basophils [#/volume] in Blood
115
763
2.31
7.10
6.4
5.9
e9/l
0.0
0.0
1.12
95
671
(3013115) Eosinophils [#/volume] in Blood
117
782
2.31
7.09
6.7
6.1
e9/l
0.2
0.2
2.87
99
699
(3002030) Lymphocytes/100 leukocytes in Blood
110
722
2.26
6.89
7.1
6.0
%
21.8
26.5
3.90
103
682
(3001604) Monocytes [#/volume] in Blood
114
762
2.26
6.80
6.4
5.8
e9/l
0.6
0.6
0.12
94
666
(3018010) Neutrophils/100 leukocytes in Blood
109
719
2.23
6.67
6.6
5.8
%
62.0
58.0
2.55
101
682
(42870588) Differential panel, method unspecified - Blood
85
512
2.20
6.47
7.6
5.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
113
763
2.21
6.44
7.5
7.4
mmol/l
1.2
1.2
0.04
93
637
(3019198) Lymphocytes [#/volume] in Blood
114
781
2.17
6.15
6.5
5.9
e9/l
1.9
1.8
0.08
96
699
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
55
287
2.30
5.84
8.2
3.1
mmol/l
2.5
2.4
2.93
48
250
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
40
183
2.51
5.67
7.1
3.8
u/l
222.8
239.6
0.44
40
175
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
7
13.42
5.64
4.7
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
166
2.53
5.46
3.7
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
124
2.69
5.20
3.8
2.5
ml/min/173m2
65.6
64.0
—
8
57
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
78
3.06
5.02
1.8
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
197
2.31
4.79
1.7
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
184
2.34
4.73
3.1
3.5
umol/l
5.1
10.0
2.43
31
163
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
173
2.34
4.55
1.9
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
247
2.14
4.45
2.0
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
177
2.28
4.31
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
134
1061
1.92
3.93
5.4
3.5
pmol/l
14.1
14.8
3.22
129
944
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
177
2.20
3.91
1.9
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
15
6.24
3.86
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
93
663
1.80
3.80
15.4
10.5
e9/l
0.0
0.0
0.53
70
548
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
27
126
2.33
3.63
3.9
3.1
u/l
42.2
38.7
0.08
22
104
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
22
94
2.52
3.57
6.9
10.5
mmol/l
24.7
24.4
0.13
17
87
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
18
5.19
3.41
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
18
5.19
3.41
1.8
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
248
1.95
3.38
2.2
2.7
e6/l
1.3
1.2
0.05
25
137
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
171
1512
2.45
3.23
28.0
15.4
mg/l
25.4
24.6
0.14
156
1214
(3052851) Hemolysis interference index of Serum or Plasma
14
50
2.94
3.16
3.1
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
577
0.52
3.13
3.6
3.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
16
5.17
3.08
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
31
522
0.51
2.93
3.8
3.9
mg/mmol
12.0
8.1
0.23
16
350
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
129
1488
0.58
2.92
5.0
6.1
mmol/mol
39.3
40.6
0.95
111
1394
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
91
2.34
2.85
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.06
2.81
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.06
2.81
1.4
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
29
482
0.53
2.58
2.6
3.1
mg/l
138.9
58.2
0.56
17
323
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
7
7.30
2.56
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
11
5.59
2.56
1.2
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
34
199
1.86
2.54
6.9
8.6
kpa
5.4
5.1
1.13
29
188
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
155
1355
1.82
2.52
5.9
4.2
mu/l
3.9
2.0
2.37
145
1222
(3030467) Casts [#/volume] in Urine by Automated count
62
435
1.63
2.46
2.5
3.0
e6/l
0.3
0.7
1.27
48
327
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
139
1556
0.59
2.43
3.7
4.8
mmol/l
4.6
4.5
0.18
126
1443
(3003396) Base excess in Arterial blood by calculation
34
202
1.83
2.43
6.8
8.7
mmol/l
1.5
0.9
0.32
26
160
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
267
1.74
2.40
2.0
2.5
e6/l
0.8
1.1
0.31
24
155
(3009508) Creatinine [Moles/volume] in Urine
32
501
0.56
2.28
2.8
3.0
mmol/l
9.1
8.3
0.32
24
418
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
297
1.68
2.24
5.7
3.9
ng/l
193.6
282.4
0.18
38
242
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
139
1548
0.61
2.21
3.6
4.7
mmol/l
1.4
1.4
1.06
125
1428
(3051611) Lipemic interference index of Serum or Plasma
7
19
3.78
2.17
3.1
4.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
14
4.39
2.17
3.3
4.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
65
475
1.56
2.14
2.7
3.2
e6/l
14.1
208.0
0.83
51
372
(36304419) Bacteria [Presence] in Urine
57
410
1.56
1.99
2.6
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
21
3.42
1.98
1.9
2.9
%
66.1
56.3
—
7
21
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
21
3.42
1.98
1.6
2.3
e9/l
3.3
5.0
—
7
21
(3045788) Cell count panel - Pleural fluid
5
11
4.64
1.95
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
136
1511
0.64
1.92
3.4
4.2
mmol/l
1.3
1.4
0.17
122
1389
(3018095) Leukocytes [#/volume] in Urine
70
532
1.50
1.89
3.0
3.6
e6/l
12.0
127.3
1.15
53
392
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
162
1470
1.74
1.86
26.2
13.9
ml/min/173m2
83.4
79.5
1.86
151
1201
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
23
3.12
1.81
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
246
1.63
1.78
2.1
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
2.6
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
57
739
0.67
1.71
3.1
3.6
estimate
0.0
0.0
0.00
13
120
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
146
1587
0.64
1.66
4.0
5.3
mmol/l
2.7
2.7
0.02
129
1467
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.06
1.59
2.3
1.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
33
2.49
1.55
1.9
8.1
iu/ml
—
135.9
—
0
7
(21494434) Karyotype in Bone marrow
5
15
3.39
1.53
1.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
15
3.39
1.53
1.4
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
15
3.39
1.53
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
15
3.39
1.53
1.0
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
22
134
1.73
1.47
6.8
9.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
150
1.69
1.46
6.8
7.6
mmol/l
1.2
1.4
0.92
19
144
(3027945) Reticulocytes/100 erythrocytes in Blood
29
191
1.61
1.46
2.0
2.5
%
1.8
1.9
0.21
22
177
(3016502) Oxygen saturation in Arterial blood
28
183
1.62
1.45
8.1
9.1
%
94.8
96.0
0.19
28
176
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
39
2.37
1.45
1.2
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
16
3.18
1.44
2.0
2.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
63
492
1.42
1.42
2.2
2.1
u/l
196.1
212.2
0.11
57
459
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
23
2.66
1.38
1.2
1.7
ug/l
13.1
17.5
—
6
23
(3021601) Nitrite [Presence] in Urine by Test strip
58
727
0.71
1.37
3.8
4.9
estimate
0.0
0.0
0.00
15
133
(40768441) Liver Pathology biopsy report
5
17
2.99
1.36
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
42
306
1.48
1.36
2.5
3.1
mosm/kgh2o
530.8
580.7
0.63
33
258
(3041096) Erythrocytes [Presence] in Urine by Automated
29
413
0.65
1.33
3.1
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
58
723
0.71
1.31
2.9
3.6
estimate
0.0
0.0
0.00
15
130
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
34
2.41
1.31
2.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
214
1.54
1.29
1.2
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
66
528
1.39
1.28
3.8
2.8
u/l
47.9
56.4
1.35
61
495
(3007164) IgA [Mass/volume] in Serum or Plasma
16
260
0.58
1.27
1.2
1.3
g/l
1.8
2.7
—
6
165
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
26
2.35
1.19
2.3
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
30
2.38
1.13
1.0
1.8
%
60.4
64.5
—
7
30
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
32
2.23
1.09
2.1
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
32
2.23
1.09
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
147
0.52
1.09
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
189
0.56
1.08
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
120
1072
1.33
1.07
3.6
3.5
u/l
69.1
59.9
0.49
107
1006
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
28
199
1.48
1.03
1.7
1.8
%
2.7
1.6
1.13
22
173
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
39
501
0.72
1.02
2.1
3.2
ng/l
2722.8
1212.3
0.35
33
422
(3019060) Gas panel - Arterial blood
19
124
1.59
1.01
4.9
5.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
31
226
1.45
1.01
5.5
7.8
mmol/l
104.6
103.5
0.80
31
219
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
35
2.04
1.01
1.1
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
67
565
1.29
0.88
2.9
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
123
1120
1.28
0.86
3.9
4.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
113
0.52
0.86
3.8
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
113
1.55
0.85
1.8
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
46
1.77
0.83
2.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
168
1602
1.46
0.82
21.8
14.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
33
1.84
0.80
1.0
1.3
—
85.7
—
0
7
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
25
0.00
0.79
0.0
1.2
—
7.8
—
0
15
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.0
—
32.7
—
0
7
(3029937) Albumin [Presence] in Urine by Test strip
30
384
0.74
0.76
3.7
3.8
estimate
0.0
0.0
0.00
12
126
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
33
416
0.75
0.76
1.4
1.7
mmol/l
1.2
1.4
1.12
26
353
(3002385) Erythrocyte distribution width [Ratio]
135
1255
1.27
0.73
34.5
18.3
%
13.9
13.7
0.96
135
1234
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
40
1.78
0.72
1.1
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
26
1.95
0.71
2.6
3.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
77
1.60
0.70
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
172
1657
1.45
0.68
30.8
18.0
umol/l
78.5
82.9
1.45
172
1657
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
90
806
1.22
0.67
2.2
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
221
0.70
0.65
3.9
4.7
%
35.0
31.4
0.76
11
142
(3000850) Epithelial cells [#/volume] in Urine
40
328
1.28
0.64
2.2
2.6
e6/l
8.7
3.8
0.52
32
281
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
328
1.28
0.64
1.4
1.8
mg/l
1.9
1.4
0.48
30
266
(1761868) Lipid panel - Serum or Plasma
49
574
0.80
0.63
2.5
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
46
387
1.25
0.60
2.5
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
54
1.50
0.58
2.1
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
22
169
1.34
0.56
8.9
9.7
g/l
114.7
121.4
0.82
22
164
(3027315) Oxygen [Partial pressure] in Blood
6
37
1.64
0.56
8.8
4.0
kpa
9.7
8.4
—
6
37
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
37
1.64
0.56
1.5
1.9
%
234.0
192.7
—
6
37
(3013290) Carbon dioxide [Partial pressure] in Blood
6
37
1.64
0.56
8.8
4.0
kpa
4.9
5.0
—
6
37
(3024928) Oxygen saturation in Venous blood
6
38
1.60
0.55
1.0
2.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
365
1.23
0.53
2.2
1.9
mg/l
2.7
3.2
0.58
33
323
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
118
1.39
0.52
2.1
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
65
1.40
0.51
2.0
3.2
—
—
—
0
0
(3020891) Body temperature
9
65
1.40
0.51
3.8
5.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
45
1.58
0.49
2.1
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
46
1.54
0.49
1.4
1.5
—
—
—
0
0
(3000492) Spirometry study
12
163
0.72
0.46
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
50
1.42
0.45
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
104
1.37
0.44
1.2
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
94
0.63
0.43
1.0
1.2
—
35.7
—
0
8
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
96
1.38
0.43
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
57
1.42
0.42
2.5
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
87
938
0.87
0.41
3.9
4.5
ug/l
2.5
2.3
0.12
77
844
(1616796) Gas panel - Central venous blood
5
33
1.53
0.41
8.4
3.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
59
1.37
0.41
1.6
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4024509)
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
16
0.00
0.41
0.0
1.5
—
4.4
—
0
7
(4146454)
0
16
0.00
0.41
0.0
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
68
746
0.86
0.41
3.4
4.1
%
21.0
21.7
0.16
29
337
(3005570) Glucose [Moles/volume] in Urine
0
17
0.00
0.41
0.0
2.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
103
0.67
0.40
1.3
2.4
—
17.1
—
0
5
(3002179) Metamyelocytes/100 leukocytes in Blood
15
115
1.33
0.40
6.1
3.8
%
0.5
0.4
—
6
31
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.0
—
1.2
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
2.7
—
686.3
—
0
8
(3003327) Ova and parasites identified in Stool by Light microscopy
5
35
1.44
0.39
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
67
1.36
0.38
1.0
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
9
71
1.28
0.36
6.7
6.7
%
1.3
0.9
—
9
66
(3005322) IgE [Units/volume] in Serum or Plasma
5
76
0.65
0.36
1.0
1.2
u/ml
17.5
194.5
—
5
67
(3049717) Cytology report of Urine Cyto stain
5
77
0.64
0.36
2.6
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
78
0.63
0.36
2.2
4.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
125
0.71
0.36
3.1
3.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
628
0.87
0.36
2.1
2.0
pmol/l
91.8
94.0
0.15
33
341
(3013707) Erythrocyte sedimentation rate by Westergren method
118
1120
1.14
0.36
3.2
4.1
mm/h
14.3
12.4
0.56
108
1025
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
43
1.41
0.35
1.0
1.7
%
80.7
82.2
—
6
43
(3037467) Urinalysis macro (dipstick) panel - Urine
108
1021
1.14
0.34
3.5
3.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
89
0.66
0.33
1.2
1.9
—
—
—
0
0
(3019225) pH of Specimen
20
165
1.24
0.33
4.0
4.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
120
1.27
0.31
6.9
3.9
%
0.0
0.2
—
7
41
(21494755) Public health laboratory ask at order entry panel
11
140
0.77
0.29
1.3
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
149
1532
0.87
0.29
3.8
4.8
mmol/l
5.9
6.1
2.00
138
1412
(3023520) Reticulocytes [#/volume] in Blood
17
141
1.23
0.27
2.2
2.7
e9/l
64.6
74.3
0.49
11
109
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
74
0.67
0.26
1.4
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
83
0.71
0.24
1.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
37
1.36
0.23
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
37
1.36
0.23
1.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
94
0.73
0.23
1.4
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
163
1.18
0.22
1.2
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
101.8
—
0
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
10.8
—
935.8
—
0
11
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
4.6
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
15.6
—
1594.5
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
11
0.00
0.21
0.0
2.5
—
16.4
—
0
5
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
119.9
—
0
6
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
54.8
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
17.8
—
0
10
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
6.4
—
0
10
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
37
337
1.12
0.21
3.7
4.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
13
0.00
0.21
0.0
3.3
—
527.0
—
0
6
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
30
332
0.89
0.20
1.5
1.7
pmol/l
440.3
440.0
0.00
24
286
(3019309) Folate [Moles/volume] in Red Blood Cells
33
299
1.13
0.20
2.1
1.7
nmol/l
899.4
1238.9
1.89
25
227
(3001019) Free T4 and TSH panel - Serum or Plasma
6
49
1.23
0.20
1.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
58
1.21
0.18
2.3
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
66
0.75
0.17
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
6
75
0.79
0.16
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
78
0.76
0.16
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
31
336
0.91
0.15
2.3
3.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
133
1300
1.08
0.15
30.5
19.0
g/l
332.6
333.9
1.08
133
1295
(3022313) Gas panel - Capillary blood
7
88
0.79
0.15
4.4
2.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
161
1.13
0.13
1.2
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
69
663
1.06
0.12
3.3
3.9
ng/l
39.4
47.8
0.22
55
480
(3025159) Blasts/100 leukocytes in Blood
13
114
1.15
0.12
7.8
4.0
%
0.2
0.0
—
6
34
(3017181) Myelocytes/100 leukocytes in Blood
15
135
1.12
0.10
6.9
3.7
%
1.0
1.0
—
7
47
(40761536) Microorganisms panel - Urine sediment
13
116
1.13
0.09
4.2
4.2
—
—
—
0
0
(3012544) pH of Venous blood
17
155
1.11
0.09
1.8
3.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
55
1.09
0.09
3.5
4.7
mmol/l
3.9
4.0
—
6
49
(3001122) Ferritin [Mass/volume] in Serum or Plasma
60
580
1.05
0.08
2.3
2.4
ug/l
191.8
170.2
0.23
53
542
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
72
0.83
0.08
6.7
3.5
u/ml
6.2
204.8
—
6
59
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
122
0.90
0.07
1.4
3.3
ng/l
372.3
192.7
0.29
11
102
(3013512) EKG study
51
493
1.05
0.07
4.5
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
60
584
1.04
0.06
2.1
2.2
nmol/l
71.3
76.0
0.54
50
515
(3000963) Hemoglobin [Mass/volume] in Blood
172
1709
1.08
0.05
37.7
22.1
g/l
129.0
138.7
10.75
172
1686
(3035941) MCH [Entitic mass]
172
1709
1.08
0.05
37.2
21.9
pg
30.7
30.5
0.35
172
1687
(3024731) MCV [Entitic volume]
172
1709
1.08
0.05
37.2
21.9
fl
92.1
91.3
1.20
172
1687
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
544
0.96
0.05
2.6
2.9
ug/l
0.8
0.7
0.15
38
346
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
200
0.94
0.04
7.1
7.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
12
114
1.06
0.01
7.8
8.8
mmol/l
25.6
24.2
0.51
12
106
(3021960) Folate [Moles/volume] in Serum or Plasma
38
374
1.02
0.00
1.4
1.6
nmol/l
19.0
20.6
0.29
29
322
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
96
1.04
0.00
10.4
9.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
139
1385
1.01
0.00
28.6
15.6
%
39.5
40.7
1.76
115
987
(4010399)
12
122
0.98
0.00
1.2
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.2
—
8.6
—
0
9
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.8
—
0.5
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
210
1.00
0.00
1.2
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
77
0.91
0.00
1.3
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
24.5
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.5
—
213.8
—
0
8
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.4
—
12.9
—
0
7
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
51
0.98
0.00
9.8
8.3
mmol/l
1.4
1.3
—
5
45
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.6
—
71.5
—
0
8
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.3
—
108.5
—
0
6
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
7.9
—
0
6
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BASEOFTONGUE – Malignant neoplasm of base of tongue
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).